课题基金 / 基金详情

A targeted anti-HIV drug delivery to the GALT

A targeted anti-HIV drug delivery to the GALT
向 GALT 输送靶向抗 HIV 药物
批准号:
10218032
负责人:
Upal Roy
金额:
$65.79万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-16 至 2025-06-30

项目摘要

项目成果

Upal Roy的其他基金

相似基金

相关文献

中文摘要
翻译
人类免疫缺陷病毒1型(HIV-1)仍然是全球主要的死亡原因之一 主要是在资源有限的国家。目前的联合抗逆转录病毒疗法(CART) 显著降低了患者的疾病死亡率。然而,这种病毒仍然持续存在 病毒储存器官,如肠道相关淋巴组织(GalT)。大多数购物车上都有毒品 由于高尔特油层的复杂生理,未能根除它。在这方面,药物 特别是在治疗水平上延伸到远程淋巴组织 时间的长短将是当前的兴趣所在。考虑将下一代艾滋病毒-1疗法作为 艾滋病研究办公室优先研究领域,我们建议开发一种以纳米药物为基础的 针对高尔特微折叠细胞(M细胞)的长效抗艾滋病毒药物配方。M细胞是 主要存在于胃肠道的特化上皮细胞。IT有效地 将许多小分子运输到底层的粘膜免疫系统。考虑到 M细胞的穿细胞性,我们开发了一种含有三个 目前推荐的抗艾滋病毒药物(也称为纳米毯)。这种纳米地毯是生物偶联的 以抗M细胞特异性抗体为靶向给药至M细胞。我们假设一个M- 细胞介导的药物传递将比传统药物更持久和有效 高尔特。
英文摘要
Human Immunodeficiency Virus 1 (HIV-1) remains one of the leading causes of death worldwide predominantly in resource-limited countries. The present Combined Antiretroviral Therapy (cART) has significantly reduced disease mortality among patients. However, the virus still persists in viral reservoir organs such as Gut-associated lymphoid tissue (GALT). Mostly cART drugs have failed to eradicate GALT reservoir because of its complex physiology. In this regard, drugs that specifically reach out to that remote lymphatic tissue at therapeutic level for an extended period of time will be of current interest. Considering the next-generation therapy for HIV-1 as one of the priority research areas of Office of AIDS Research, we propose to develop a nanomedicine based long-acting anti-HIV drug formulation targeting Microfold cells (M-cell) in the GALT. M-cells are specialized epithelial cells that are predominantly present in the gastrointestinal tract. It effectively transports many micromolecules to the underlying mucosal immune system. Considering the transcytosis property of M-cell, we have developed a pluronic nanocarrier containing three currently recommended anti-HIV drugs (also called nanodrug). This nanodrug is bio-conjugated with anti-M-cell specific antibody for targeted drug delivery to M-cell. We hypothesize that an M- cell mediated drug delivery will be more sustained and effective than conventional drugs to the GALT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A targeted anti-HIV drug delivery to the GALT
A targeted anti-HIV drug delivery to the GALT
A targeted anti-HIV drug delivery to the GALT
海外基金